DK8591D0 - Interleukin-l inhibotor - Google Patents

Interleukin-l inhibotor

Info

Publication number
DK8591D0
DK8591D0 DK008591A DK8591A DK8591D0 DK 8591 D0 DK8591 D0 DK 8591D0 DK 008591 A DK008591 A DK 008591A DK 8591 A DK8591 A DK 8591A DK 8591 D0 DK8591 D0 DK 8591D0
Authority
DK
Denmark
Prior art keywords
inhibotor
interleukin
Prior art date
Application number
DK008591A
Other languages
English (en)
Other versions
DK172763B1 (da
DK8591A (da
Inventor
Charles H Hannum
Stephen P Eisenberg
Robert C Thompson
William P Arend
Fenneke G Joslin
Andreas Sommer
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of DK8591A publication Critical patent/DK8591A/da
Publication of DK8591D0 publication Critical patent/DK8591D0/da
Application granted granted Critical
Publication of DK172763B1 publication Critical patent/DK172763B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK199100085A 1988-05-27 1991-01-18 Isoleret interleukin-1 (IL-1) inhibitor eller forstadiepolypeptid dertil, isoleret DNA-molekyle, som koder derfor, vektor o DK172763B1 (da)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US19991588A 1988-05-27 1988-05-27
US19991588 1988-05-27
US23871388A 1988-08-31 1988-08-31
US23871388 1988-08-31
US26653188A 1988-11-03 1988-11-03
US26653188 1988-11-03
US8902275 1989-05-25
PCT/US1989/002275 WO1989011540A1 (en) 1988-05-27 1989-05-25 Interleukin-1 inhibitors

Publications (3)

Publication Number Publication Date
DK8591A DK8591A (da) 1991-01-18
DK8591D0 true DK8591D0 (da) 1991-01-18
DK172763B1 DK172763B1 (da) 1999-07-05

Family

ID=27394086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199100085A DK172763B1 (da) 1988-05-27 1991-01-18 Isoleret interleukin-1 (IL-1) inhibitor eller forstadiepolypeptid dertil, isoleret DNA-molekyle, som koder derfor, vektor o

Country Status (9)

Country Link
JP (2) JP3192651B2 (da)
KR (1) KR970002917B1 (da)
BR (1) BR8907457A (da)
DK (1) DK172763B1 (da)
FI (2) FI109206B (da)
HU (3) HU9803037D0 (da)
NO (2) NO316122B1 (da)
OA (1) OA09631A (da)
WO (1) WO1989011540A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
EP0534978B1 (en) * 1990-05-01 1999-03-24 Chiron Corporation Interleukin-1 antagonist and uses thereof
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
US5824549A (en) * 1990-10-09 1998-10-20 Chiron Corporation Transformed human T cell
US5932537A (en) * 1990-10-09 1999-08-03 Chiron Corporation Method for attenuating a cellular response to IL-1
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
US20030103978A1 (en) 2000-02-23 2003-06-05 Amgen Inc. Selective binding agents of osteoprotegerin binding protein
EP1442132A2 (en) * 2001-10-26 2004-08-04 Novartis AG Methods for the treatment of osteoarthritis and compositions thereof
JP4761710B2 (ja) 2002-04-05 2011-08-31 アムジェン インコーポレイテッド 選択的ｏｐｇｌ経路インヒビターとしてのヒト抗ｏｐｇｌ中和抗体
ES2414460T3 (es) 2004-08-04 2013-07-19 Amgen Inc. Anticuerpos para Dkk-1
HUE037265T2 (hu) 2007-08-21 2018-08-28 Amgen Inc Humán c-fms antigént kötõ proteinek
WO2010030979A2 (en) * 2008-09-12 2010-03-18 Xbiotech, Inc. Targeting pathogenic monocytes
WO2012025910A1 (en) 2010-08-26 2012-03-01 Centro De Investigación Y De Estudios Avanzados Del Instituto Politécnico Nacional METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOARTHRITIS AT EARLY STAGES USING INTERLEUKIN IL-1ß AS EARLY BIOMARKER OF THE DISEASE
CN103476933B (zh) 2011-03-14 2016-04-13 弗洛格有限公司 白介素1受体的拮抗剂
JP2014519480A (ja) 2011-04-15 2014-08-14 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌で使用される抗ｉｌ−１ｒ１阻害物質
TW201605896A (zh) 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
WO2015087187A1 (en) 2013-12-10 2015-06-18 Rinat Neuroscience Corp. Anti-sclerostin antibodies
CA3016894A1 (en) 2016-03-08 2017-09-14 Janssen Biotech, Inc. Gitr antibodies, methods, and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8820676A (nl) * 1987-08-26 1989-07-03 Biogen Inc Biologische materialen, werkwijzen ter bereiding van biologische materialen en de toepassing van dergelijke materialen in therapie.

Also Published As

Publication number Publication date
WO1989011540A1 (en) 1989-11-30
DK172763B1 (da) 1999-07-05
HU9803037D0 (en) 1999-11-29
NO316122B1 (no) 2003-12-15
HU215434B (hu) 1999-04-28
AU3746989A (en) 1989-12-12
FI109206B (fi) 2002-06-14
JP3192651B2 (ja) 2001-07-30
DK8591A (da) 1991-01-18
FI20020545A (fi) 2002-03-21
JPH03505279A (ja) 1991-11-21
KR970002917B1 (ko) 1997-03-12
NO905090L (no) 1991-01-28
JP2001029093A (ja) 2001-02-06
FI905812A0 (fi) 1990-11-26
HU893412D0 (en) 1991-05-28
NO20014783L (no) 1991-01-28
NO905090D0 (no) 1990-11-23
NO20014783D0 (no) 2001-10-01
BR8907457A (pt) 1991-04-02
AU633831B2 (en) 1993-02-11
HU222810B1 (hu) 2003-11-28
OA09631A (en) 1993-04-30
NO316917B1 (no) 2004-06-21

Similar Documents

Publication Publication Date Title
FR2632154B1 (fr) Moissonneuse
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
DK8591D0 (da) Interleukin-l inhibotor
DK591189D0 (da) Lamelportfloej
DE68926597T2 (de) Mikrorechner
BR8902098A (pt) Eletrolisador
BR8906898A (pt) Jamela
DK137889D0 (da) Foldeaeske
DK100890A (da) Spjaeldregulerende arrangement
DK165575C (da) Loeftesele
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
DD277186A3 (de) Waelzlagerseparator
DK536788D0 (da) Foldeaeske
FI88381C (fi) Kraftoeverfoerings- och styrarrangemang foer fordon
IT214385Z2 (it) Contenitore-espositore
SE8800012D0 (sv) Steril - koppling
BR6800108U (pt) Supercross
IT8808703V0 (it) Contabarbe
IT8846501A0 (it) Vetroch
BR8801701A (pt) Anti-ivh
BR8907290A (pt) Diisopropilbenzeno-bis-peneoalcanoatos
SE8801863D0 (sv) Vattenrefsa

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AGE Re-establishment of rights: approved
B1 Patent granted (law 1993)
PUP Patent expired